NFKB1 and neoplasm: Some studies have shown that the activity of NF-κB pathway proteins is indeed related to lymph node metastasis, tumour size, invasion and other clinicopathological characteristics and may contribute to the development of tumour cells that are resistant to chemoradiotherapy.